"Insulin-Secreting Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
    
			
			
				
				
					
						| Descriptor ID | D050417 | 
					
						| MeSH Number(s) | A03.734.414.131 A06.390.131 A06.407.414.087 A11.382.625.092 A11.436.294.092 | 
					
						| Concept/Terms | Insulin-Secreting CellsInsulin-Secreting CellsCell, Insulin-SecretingCells, Insulin-SecretingInsulin Secreting CellsInsulin-Secreting Cellbeta Cells, PancreaticPancreatic beta Cellbeta Cell, PancreaticPancreatic B CellsB Cell, PancreaticB Cells, PancreaticPancreatic B CellPancreatic beta Cells
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Insulin-Secreting Cells".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Insulin-Secreting Cells".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Insulin-Secreting Cells" by people in this website by year, and whether "Insulin-Secreting Cells" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2006 | 2 | 1 | 3 | 
| 2008 | 1 | 0 | 1 | 
| 2009 | 2 | 1 | 3 | 
| 2010 | 0 | 1 | 1 | 
| 2012 | 1 | 0 | 1 | 
| 2013 | 3 | 0 | 3 | 
| 2014 | 2 | 0 | 2 | 
| 2017 | 0 | 1 | 1 | 
| 2018 | 3 | 0 | 3 | 
| 2025 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Insulin-Secreting Cells" by people in Profiles.
						
					
								- 
								Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion. Sci Adv. 2025 Jan 10; 11(2):eadr1725. 
- 
								Impact of Gastric Banding Versus Metformin on ß-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Diabetes Care. 2018 12; 41(12):2544-2551. 
- 
								Association of weight gain and fifteen adipokines with declining beta-cell function in Mexican Americans. PLoS One. 2018; 13(8):e0201568. 
- 
								Elevated Medium-Chain Acylcarnitines Are Associated With Gestational Diabetes Mellitus and Early Progression to Type 2 Diabetes and Induce Pancreatic ß-Cell Dysfunction. Diabetes. 2018 05; 67(5):885-897. 
- 
								A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants. Diabetes. 2017 08; 66(8):2296-2309. 
- 
								Diabetes Pathology and Risk of Primary Open-Angle Glaucoma: Evaluating Causal Mechanisms by Using Genetic Information. Am J Epidemiol. 2016 Jan 15; 183(2):147-55. 
- 
								High calorie intake is associated with worsening insulin resistance and ß-cell function in Hispanic women after gestational diabetes mellitus. Diabetes Care. 2014 Dec; 37(12):3294-300. 
- 
								Genetic variation in MTNR1B is associated with gestational diabetes mellitus and contributes only to the absolute level of beta cell compensation in Mexican Americans. Diabetologia. 2014 Jul; 57(7):1391-9. 
- 
								Restoring Insulin Secretion (RISE): design of studies of ß-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes Care. 2014; 37(3):780-8. 
- 
								Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus. Diabetologia. 2013 Dec; 56(12):2753-60.